TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study

The long-term survival of patients with hepatocellular carcinoma (HCC) with portal vein tumour thrombus (PVTT) is poor. Systemic therapy, transcatheter arterial chemoembolization (TACE), and hepatic artery infusion chemotherapy are widely used in HCC patients with PVTT. This study aims to explore th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Yichuan, He, Wei, Yang, Zhiwen, Qiu, Jiliang, Huang, Zhenkun, Shi, Yunxing, Lin, Zhu, Zheng, Yun, Chen, Minshan, Lau, Wan Yee, Li, Binkui, Yuan, Yunfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389515/
https://www.ncbi.nlm.nih.gov/pubmed/37026861
http://dx.doi.org/10.1097/JS9.0000000000000256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389515/
https://www.ncbi.nlm.nih.gov/pubmed/37026861
http://dx.doi.org/10.1097/JS9.0000000000000256

Ejemplares similares